Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers

Rhea-AI Summary

Evolus announced significant milestones for its Evolus Rewards™ patient loyalty program, surpassing 1 million enrolled consumers and achieving 2 million Jeuveau® redemptions. The SMS-based program, launched in 2020, offers patients $40 off Jeuveau® treatments every 90 days at participating providers. The company plans to launch Club Evolus™, the industry's first subscription-based consumer membership program from a neurotoxin manufacturer, on November 4, 2024. Notably, more than half of new program entrants are millennials or younger, and participating practices experience significantly higher revenue growth compared to non-participating practices.

Positive

• Reached 1 million enrolled consumers in loyalty program
• Achieved 2 million Jeuveau® treatment redemptions
• Participating practices show significantly higher revenue growth
• Strong millennial customer acquisition, representing over 50% of new entrants

Negative

• None.

Insights

Market Research Analyst

The milestone of 1 million enrolled consumers and 2 million Jeuveau® redemptions signals robust market penetration and strong consumer adoption. The $40 instant savings program is driving significant customer acquisition and retention, particularly among millennials - a important demographic for long-term growth. The upcoming Club Evolus™ subscription model represents a strategic move to increase recurring revenue and customer lifetime value.

Participating practices showing higher revenue growth validates the program's effectiveness as a practice-building tool. The co-branded, SMS-based system reduces friction in the customer journey while building brand loyalty. This digital-first approach aligns well with younger consumer preferences and positions Evolus competitively in the growing aesthetic neurotoxin market.

• Achieves 2 Million Jeuveau^® Redemptions
• Anticipates Launch of Club Evolus^™, the first consumer membership program by a neurotoxin manufacturer, on November 4, 2024

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it recently surpassed one million enrolled consumers and completed the two-millionth Jeuveau^® redemption in its Evolus Rewards^™ patient loyalty program.

“The achievement of these milestones underscores the success of our strategy to democratize beauty and make aesthetics accessible to a new generation of consumers,” said David Moatazedi, President and Chief Executive Officer. “Our easy-to-use, SMS-based loyalty program offers consumers an instant $40 savings on every Jeuveau^® treatment, while providing practices with the only co-branded solution to encourage repeat visits. We’re proud of the rapid adoption of this innovative program, which has grown to over 1 million consumers and achieved more than 2 million redemptions.

“We are excited to expand our loyalty offering with the upcoming launch of Club Evolus, the industry's first subscription-based consumer membership program from a neurotoxin manufacturer, debuting on November 4th. Powered by the same proprietary digital platform that enhances the practice experience, Club Evolus will offer consumers even more value and convenience.”

Evolus Rewards^™ was launched in 2020 soon after Jeuveau^® was approved by the FDA in 2019. The program offers enrolled patients $40 off Jeuveau^® treatments every 90 days at participating providers. The program enhances convenience and ease by delivering a fun, frictionless experience with instant rewards. This approach allows both patients and practices to effortlessly engage with the program.

Evolus Rewards^™ supports the company’s mission of partnering with its customers and driving consumers back to their practices with co-branded reminders and text messages, while attracting the next generation of beauty consumers considering aesthetic injectables. On average, practices participating in Evolus Rewards™ experience significantly higher revenue growth than non-participating practices.

Importantly, more than half of new entrants to Evolus Rewards^™ are millennials or younger. This demographic represents the future of the aesthetics industry and is a highly sought-after audience for providers looking to expand their businesses.

About Evolus, Inc.

Evolus (NASDAQ: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau^® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse^™, and the exclusive distributor in Europe of Estyme^®, a line of unique injectable hyaluronic acid (HA) gels. These injectable HA gels are currently in the late stages of the regulatory approval process, with plans, upon approval, for a launch starting in 2025. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.

Jeuveau^® and Nuceiva^®, are registered trademarks and Evolysse^™ is a trademark of Evolus, Inc.
Hi-Pure^™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Estyme^® is a trademark of Symatese Aesthetics S.A.S.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241029169655/en/

Investors:

Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications

Phone: (248) 202-9267

Email: ir@evolus.com

Media:

Email: media@evolus.com

Source: Evolus, Inc.

FAQ

How many consumers are enrolled in Evolus Rewards program?

Evolus Rewards has surpassed 1 million enrolled consumers.

What is the discount offered by Evolus Rewards (EOLS) for Jeuveau treatments?

Evolus Rewards offers $40 off Jeuveau treatments every 90 days at participating providers.

When will Club Evolus membership program launch?

Club Evolus, the first subscription-based consumer membership program by a neurotoxin manufacturer, will launch on November 4, 2024.

How many Jeuveau redemptions has Evolus (EOLS) achieved through its rewards program?

Evolus has achieved 2 million Jeuveau redemptions through its rewards program.